What is the recommended ceftriaxone dosing regimen for a pediatric patient with bacterial meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Meningitic Dose of Ceftriaxone

For pediatric bacterial meningitis, administer ceftriaxone 80–100 mg/kg/day divided every 12 hours (or as a single daily dose of 100 mg/kg), with a maximum of 4 grams per day, for 7–10 days depending on the causative organism. 1

Age-Stratified Dosing Algorithm

Neonates 8–21 Days Old

  • Do NOT use ceftriaxone as monotherapy 1
  • Use ampicillin 300 mg/kg/day divided every 6 hours PLUS ceftazidime 150 mg/kg/day divided every 8 hours 1
  • Ceftriaxone is contraindicated in hyperbilirubinemic neonates due to kernicterus risk 2

Neonates 22–28 Days Old

  • Ampicillin 300 mg/kg/day divided every 6 hours PLUS ceftazidime 150 mg/kg/day divided every 8 hours 1
  • Ceftriaxone may be considered but ampicillin + ceftazidime remains preferred to cover Listeria monocytogenes 1

Infants and Children 29 Days to 18 Years

  • Ceftriaxone 80–100 mg/kg/day (maximum 4 g/day) 1
  • Can be administered as:
    • 50 mg/kg every 12 hours (twice daily) 1, 3
    • 100 mg/kg once daily 1, 2, 4, 5

Dosing Frequency: Once Daily vs. Twice Daily

Recent pharmacokinetic evidence supports once-daily dosing (100 mg/kg) over twice-daily dosing (50 mg/kg every 12 hours) for empirical treatment. 6

  • Once-daily dosing achieves 88% probability of target attainment at 24 hours versus 53% for twice-daily dosing (for MIC 1 mg/L) 6
  • Both regimens achieve 100% target attainment at steady state 6
  • CSF penetration is approximately 20% of serum concentrations 6
  • Mean CSF concentrations with 100 mg/kg once daily: 6.4 mcg/mL at 3.3 hours post-dose 3
  • Mean CSF concentrations with 50 mg/kg twice daily: 5.6 mcg/mL at 3.7 hours post-dose 3

Clinical studies demonstrate equivalent efficacy between once-daily and twice-daily regimens, with once-daily offering practical advantages. 4, 5, 7

Duration of Therapy by Pathogen

Organism Duration Citation
Neisseria meningitidis 5–7 days [1,2]
Haemophilus influenzae 7–10 days [1,2]
Streptococcus pneumoniae 10–14 days [1,2]
Gram-negative enteric bacilli 21 days [2]

Critical Dosing Considerations

Maximum Dose Limits

  • Absolute maximum: 4 grams per day regardless of weight 1, 2
  • For a 50 kg child: dose would be capped at 4 g/day, not 5 g/day (100 mg/kg) 1

Adjunctive Therapy

  • Add vancomycin 60 mg/kg/day divided every 8 hours if Streptococcus pneumoniae is suspected or confirmed, targeting trough levels of 15–20 mg/mL 1
  • Vancomycin covers penicillin-resistant pneumococci (MIC >0.12 mg/L) 1, 2

Dexamethasone

  • Administer dexamethasone 0.15 mg/kg every 6 hours for 2–4 days for H. influenzae type b meningitis 1
  • Give 10–20 minutes before or concurrent with first antibiotic dose 1
  • For pneumococcal meningitis, dexamethasone use remains controversial; consider on case-by-case basis 1

Route of Administration

  • Intravenous administration is strongly preferred for meningitis 1, 2
  • Intramuscular administration is acceptable if IV access cannot be established 4, 5
  • Infuse IV doses over 30 minutes 8

Pharmacokinetic Parameters in Pediatric Meningitis

From FDA labeling and clinical studies 8, 3:

  • Elimination half-life: 4.3–5.8 hours 8, 3
  • Plasma clearance: 49–60 mL/hr/kg 8, 3
  • Volume of distribution: 338–387 mL/kg 8, 3
  • CSF concentrations (inflamed meninges): 5.6–6.4 mcg/mL (range 1.3–44 mcg/mL) 8, 3
  • Time to peak CSF concentration: 3.3–3.7 hours post-dose 8, 3

Common Pitfalls to Avoid

  1. Do not use ceftriaxone in neonates <28 days as monotherapy – must add ampicillin for Listeria coverage 1
  2. Do not use ceftriaxone in hyperbilirubinemic or premature neonates – risk of kernicterus from bilirubin displacement 2
  3. Do not underdose – 50 mg/kg once daily is insufficient; use either 50 mg/kg twice daily OR 100 mg/kg once daily 1, 6
  4. Do not omit vancomycin for suspected pneumococcal meningitis – resistance rates necessitate empiric dual coverage 1, 2
  5. Do not give dexamethasone after antibiotics have started – it is ineffective if not given before or with first antibiotic dose 1
  6. Neither once-daily nor twice-daily ceftriaxone is adequate for Staphylococcus aureus meningitis (MIC 4 mg/L) – alternative agents required 6

Practical Dosing Example

For a 5-year-old child weighing 18 kg with suspected bacterial meningitis:

  • Ceftriaxone: 100 mg/kg/day = 1,800 mg once daily IV (or 900 mg every 12 hours) 1, 6
  • Vancomycin: 60 mg/kg/day = 1,080 mg/day divided into 360 mg every 8 hours IV 1
  • Dexamethasone: 0.15 mg/kg every 6 hours = 2.7 mg every 6 hours for 2–4 days (if H. influenzae confirmed) 1
  • Duration: 7–10 days for H. influenzae, 10–14 days for S. pneumoniae 1, 2

Related Questions

What is the recommended dose of Ceftriaxone (Ceftriaxone) for pediatric patients?
What is the recommended dose of ceftriaxone (a third-generation cephalosporin antibiotic) for pediatric patients?
For a 15‑kg child with bacterial meningitis, what is the recommended intravenous antibiotic and dosage?
What is the pediatric dose of Ceftriaxone?
What is the recommended dose of Ceftriaxone (Ceftriaxone) for a 1-year-old patient with suspected or confirmed meningitis?
How should I manage a patient presenting with vomiting and sore throat?
What is the recommended initial antihypertensive regimen (including medication choice and dose) for an adult with newly diagnosed hypertension aiming for a blood pressure goal of <130/80 mm Hg?
In an AIDS patient with CD4 count 15 cells/µL, EBV detected in CSF and three intracerebral lesions, MR spectroscopy shows a necrotic core with a marked choline peak and loss of N‑acetyl‑aspartate; what is the most likely diagnosis and what are the immediate diagnostic and therapeutic steps?
Can intranasal mometasone furoate cause hypertension in otherwise healthy adults?
What is the emergent evaluation and management for a patient presenting with a unilateral headache, ipsilateral sudden vision loss, and contralateral hand numbness?
How can I safely taper vasopressin in an adult with alcoholic dilated cardiomyopathy and severe biventricular dysfunction (tricuspid annular plane systolic excursion 13 mm, left ventricular ejection fraction 25 %) who is receiving norepinephrine 10 mg/h, vasopressin 1 mg/h, and dobutamine 10 µg/h, with adequate mean arterial pressure and high urine output, to discharge on oral heart‑failure therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.